0001226555-19-000003.txt : 20190426 0001226555-19-000003.hdr.sgml : 20190426 20190426132045 ACCESSION NUMBER: 0001226555-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190426 DATE AS OF CHANGE: 20190426 EFFECTIVENESS DATE: 20190426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICONIC THERAPEUTICS INC CENTRAL INDEX KEY: 0001226555 IRS NUMBER: 161653625 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-338229 FILM NUMBER: 19770739 BUSINESS ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-437-1000 MAIL ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001226555 ICONIC THERAPEUTICS INC 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-437-1000 DELAWARE None None Corporation true William Greene 442 Littlefield Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Director Kirk Dornbush 442 Littlefield Avenue South San Francisco CA CALIFORNIA 94080 Director Todd Foley 442 Littlefield Avenue South San Francisco CA CALIFORNIA 94080 Director Julia Gregory 442 Littlefield Avenue South San Francisco CA CALIFORNIA 94080 Director Bruce Robertson 442 Littlefield Avenue South San Francisco CA CALIFORNIA 94080 Director Peter Hirth 442 Littlefield Avenue South San Francisco CA CALIFORNIA 94080 Director Bruce Cohen 442 Littlefield Avenue South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2019-04-15 false true true Ser B Prime Pref Stk; also includes Ser A Prime Pref Stk issued in exchg for shares of Com Stk issued upon conversion of shares of prior Pref Stk in a mandatory conversion effective as of immediately prior to the sale of the Ser B Prime Pref Stk. false 0 16300000 13031025 3268975 Consists of cash in the agg amount of $2,809,459.40 and cancellation of principal and accrued interest due under outstanding promissory notes in the agg amount of $8,770,675.44 which was converted at a discounted price into $10,221,565.00 of shares. false 37 0 0 500000 true Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. false ICONIC THERAPEUTICS INC /s/William L. Greene William L. Greene CEO 2019-04-26